No Data
No Data
Express News | Yield10 Bioscience Grants Nufarm a Commercial License to Omega-3 Assets for Producing Oil in Camelina, and Yield10 and Nufarm Sign a Memorandum of Understanding for Sale of Assets
Delisting of Securities of CONX Corp.; Priveterra Acquisition Corp. II; Yield10 Bioscience, Inc.; Aesthetic Medical International Holdings Group Ltd.; Breeze Holdings Acquisition Corp.; Quadro Acquisition One Corp.; DermTech, Inc.; TRACON...
Rothamsted Research Grants Yield10 Bioscience an Exclusive, Global Commercial License to Advanced Technology for Producing Omega-3 Products in Camelina
Engineered Camelina is intended to enable the land-based production of omega-3 oils used in aquafeed, petfood and human nutritionWOBURN, Mass. and HARPENDEN, United Kingdom, June 17, 2024 (GLOBE NEW
Yield10 Bioscience Announces Addition of Camelina to INTERLINE Herbicide Label
- EPA approved an amendment to the label of INTERLINE herbicideto include Camelina -The supplemental label now allows application of INTERLINE for over-the-top weed control in Camelina WOBURN, Mass.,
Hold Rating on Yield10 Bioscience Amid Commercialization Challenges and Financial Uncertainties
Yield10 Bioscience(YTEN.US) 10% Shareholder Sells US$7,200 in Common Stock
$Yield10 Bioscience(YTEN.US)$ 10% Shareholder SCHULER JACK W sold 36,000 shares of common stock on Dec 20, 2023 at an average price of $0.2 for a total value of $7,200.Source: Announcement What is sta
No Data